Skip to main content
Top

Clinical & Experimental Metastasis

Issue 5/2010

Content (8 Articles)

Research Paper

Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis

Ryan R. Gordon, Michele La Merrill, Kent W. Hunter, Peter Sørensen, David W. Threadgill, Daniel Pomp

Research Paper

Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer

Keng-Li Lan, Fu Ou-Yang, Sang-Hue Yen, How-Ling Shih, Keng-Hsin Lan

Research Paper

Characterization of a new renal cell carcinoma bone metastasis mouse model

Anne Strube, Elizaveta Stepina, Dominik Mumberg, Arne Scholz, Peter Hauff, Sanna-Maria Käkönen

Research Paper

The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action

Chih-Min Yang, Yi-Zih Liu, Jiunn-Wang Liao, Miao-Lin Hu

Research Paper

Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice

Satoshi Sakaguchi, Hisatsugu Goto, Masaki Hanibuchi, Shinsaku Otsuka, Hirokazu Ogino, Soji Kakiuchi, Hisanori Uehara, Seiji Yano, Yasuhiko Nishioka, Saburo Sone

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine